Tin tức & Cập nhật

Chỉ hiển thị Multimedia

Original New Drug Application Approvals by US FDA (16-31 March 2026)

29 Apr 2026

New drug applications approved by US FDA as of 16-31 March 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 March 2026)

29 Apr 2026

Sulfur microbial diet ups CKD risk

28 Apr 2026

Adherence to sulfur microbial diet (SMD) appears to increase the risk of chronic kidney disease (CKD), irrespective of genetic risk, suggests a study.

Sulfur microbial diet ups CKD risk

28 Apr 2026

IRIS-guided visualization enhances postpyloric feeding-tube placement in critically ill patients

28 Apr 2026

Visualization technology guided by the integrated real-time imaging system (IRIS) results in a significant decrease in procedural duration and improvements in the first-attempt success rate for postpyloric feeding-tube placement in critically ill patients, according to a study.

IRIS-guided visualization enhances postpyloric feeding-tube placement in critically ill patients

28 Apr 2026

Low-FODMAP diet, rifaximin equally efficacious in IBS with diarrhoea

28 Apr 2026

In patients with diarrhoea-predominant inflammatory bowel disease (IBS-D), a low FODMAP diet (LFD) intervention and rifaximin treatment both result in improved outcomes, as shown in a study.

Low-FODMAP diet, rifaximin equally efficacious in IBS with diarrhoea

28 Apr 2026

Which nutrition support is best for ICU patients?

27 Apr 2026

The different types of nutrition support have varying effect on the nutritional status and clinical outcomes of critically ill patients in the intensive care unit (ICU), reports a study. However, parenteral nutrition (PN) combined with enteral nutrition (EN) appears to be most effective in improving clinical outcomes and nutrition support in these patients.

Which nutrition support is best for ICU patients?

27 Apr 2026

16-year HK study: Borderline personality disorder ups risks of physical diseases and mortality

24 Apr 2026 bởi

Borderline personality disorder (BPD) is associated with higher risks of a wide range of physical diseases and increased mortality from all causes, natural causes, and external causes, according to a 16-year population-based cohort study in Hong Kong.

16-year HK study: Borderline personality disorder ups risks of physical diseases and mortality

24 Apr 2026

Health supplements: Help or hype?

22 Apr 2026 bởi

A review of 19 meta-analyses shows mixed results on the effects of multivitamin and mineral (MVM) supplementation on health outcomes.

Health supplements: Help or hype?

22 Apr 2026

IBD risk high in individuals with certain allergic diseases

19 Apr 2026

Individuals with atopic dermatitis or allergic rhinitis are at increased risk of inflammatory bowel disease (IBD), as suggested in a retrospective nested case–control study.

IBD risk high in individuals with certain allergic diseases

19 Apr 2026

First-in-class KRAS G12D–targeted protein degrader active against lung, pancreatic cancers

17 Apr 2026

The first-in-class KRAS G12D–targeted protein degrader setidegrasib has demonstrated antitumour activity in patients with previously treated advanced non–small-cell lung cancer (NSCLC) or pancreatic ductal adenocarcinoma harbouring the KRAS G12D mutation, according to a phase I study.

First-in-class KRAS G12D–targeted protein degrader active against lung, pancreatic cancers

17 Apr 2026

Silymarin plus lifestyle change improves liver health in NAFLD patients with MetS

16 Apr 2026 bởi

Silymarin therapy combined with lifestyle interventions can reduce and normalize liver enzyme levels in patients with nonalcoholic fatty liver disease (NAFLD) and associated metabolic syndrome (MetS), a recent study has shown.

Silymarin plus lifestyle change improves liver health in NAFLD patients with MetS

16 Apr 2026

Tin tức & Cập nhật

Xem bài viết Tiêu hóa

Xem

Chuyên ngành:

Original New Drug Application Approvals by US FDA (16-31 March 2026)

Original New Drug Application Approvals by US FDA (16-31 March 2026)

Sulfur microbial diet ups CKD risk

Sulfur microbial diet ups CKD risk

IRIS-guided visualization enhances postpyloric feeding-tube placement in critically ill patients

IRIS-guided visualization enhances postpyloric feeding-tube placement in critically ill patients

Low-FODMAP diet, rifaximin equally efficacious in IBS with diarrhoea

Low-FODMAP diet, rifaximin equally efficacious in IBS with diarrhoea

Which nutrition support is best for ICU patients?

Which nutrition support is best for ICU patients?

16-year HK study: Borderline personality disorder ups risks of physical diseases and mortality

16-year HK study: Borderline personality disorder ups risks of physical diseases and mortality

Health supplements: Help or hype?

Health supplements: Help or hype?

IBD risk high in individuals with certain allergic diseases

IBD risk high in individuals with certain allergic diseases

First-in-class KRAS G12D–targeted protein degrader active against lung, pancreatic cancers

First-in-class KRAS G12D–targeted protein degrader active against lung, pancreatic cancers

Silymarin plus lifestyle change improves liver health in NAFLD patients with MetS

Silymarin plus lifestyle change improves liver health in NAFLD patients with MetS